Dilated cardiomyopathy treatment at EmCell Cell Therapy Center in Kyiv, Ukraine, focuses on regenerating damaged heart muscle cells. The center holds over 30 years of experience and is the world's first clinic dedicated to fetal stem cell therapy. Patients benefit from patented methods and facilities that hold ISO 15189 and GMP accreditations.
The clinic uses fetal stem cells that can turn into new cardiomyocytes, which are specialized heart muscle cells. This regenerative approach targets the root cause of heart muscle weakness. The therapy aims to improve how well the heart pumps blood and to increase the left ventricular ejection fraction. Patients often see a reduction in BNP levels, a marker for heart failure severity. The treatment also helps increase physical activity levels and enhances overall quality of life.
EmCell operates a biotechnology lab that follows GMP compliance to prepare cell samples. Their cryobank contains 20,000+ live fetal stem cell samples. Clinical reports indicate a potential 35% life extension in cases of ischemic heart disease treated with these methods. The clinic supports its results with peer-reviewed publications and decades of clinical practice.
Treatment programs include long-term follow-up to monitor the heart's recovery. You can request a consultation to learn more about the stem cell therapy protocol by leaving a request on Bookimed.
Individual treatment program and cost estimate
Average answering time – 5 minutes
| treatment | Price | |
|---|---|---|
| Pulmonary hypertension stem cell treatment | Price on request |
EmCell is recognized as the world’s first clinic to specialize in fetal stem cell therapy. With more than 30 years of clinical experience, the center has developed effective treatment protocols for conditions such as autism, diabetes, neurodegenerative disorders, and anti-aging. It began its work with treating aplastic anemia and continues expanding its expertise in regenerative medicine.
EmCell’s clinical department is led by medical doctors who were instrumental in developing the clinic’s patented fetal stem cell therapy. The team includes experienced neurologists, cardiologists, and general physicians, supported by skilled nurses and assistants. Comprehensive diagnostic evaluations—including ultrasound, ECG, EchoCG, Doppler studies, spirography, and densitometry—are conducted before treatment, followed by careful post-treatment monitoring to ensure safety and effectiveness.
The laboratory complex features a GMP-compliant Biotechnological Laboratory where fetal stem cell preparations are created using proprietary techniques. These preparations serve as the foundation of EmCell’s therapeutic programs. The department rigorously tests all materials throughout each stage, from donor screening to final release, to meet strict quality standards.
The PCR Laboratory performs real-time polymerase chain reaction testing to detect viral and bacterial pathogens such as HIV, HCV, HBV, CMV, HPV, and COVID-19, ensuring the safety of stem cell materials. EmCell also operates an ISO 15189-accredited Clinical-Diagnostic Laboratory offering a wide range of tests, including immunophenotyping, biochemical analysis, cytology, and hormone profiling.
The clinic maintains a cryobank housing over 20,000 live fetal stem cell samples preserved through advanced cryopreservation methods. This resource enables personalized treatment approaches and supports consistent clinical outcomes.
EmCell’s R&D division is dedicated to improving the efficacy of fetal stem cell therapies and expanding treatment options through continuous innovation and product development.
The clinic provides comprehensive patient support throughout the treatment journey. Each treatment package includes pick-up services from train or bus stations in Kyiv, daily transfers between the hotel and clinic, and interpreter support to facilitate clear communication with the medical team. Patients also undergo a series of examinations, such as abdominal and thyroid ultrasounds, ECG, and laboratory tests.
Following treatment, EmCell maintains long-term communication with each patient. A dedicated follow-up manager and the treating physician remain available to answer questions, provide additional recommendations, and track post-treatment progress.
Individual treatment program and cost estimate
Average answering time – 5 minutes